Effect of nintedanib on non‐small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review

Nintedanib has been approved for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, in EU countries, nintedanib plus docetaxel is used for patients with advanced non‐small cell lung cancer (NSCLC) after first‐line chemotherapy. Here, we report a case of advanced NSCLC in a patient wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Shiratori, Toshihiro, Tanaka, Hisashi, Tabe, Chiori, Tsuchiya, Junichiro, Ishioka, Yoshiko, Itoga, Masamichi, Taima, Kageaki, Takanashi, Shingo, Tasaka, Sadatomo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262881/
https://ncbi.nlm.nih.gov/pubmed/32285615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13437
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados